✦ LIBER ✦

Deferred combined androgen blockade therapy using bicalutamide in patients with hormone-refractory prostate cancer during androgen deprivation monotherapy

✍ Scribed by YASUHISA FUJII; SATORU KAWAKAMI; HITOSHI MASUDA; TSUYOSHI KOBAYASHI; NOBUHIKO HYOCHI; YUKIO KAGEYAMA; KAZUNORI KIHARA

Book ID: 109052505
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 126 KB
Volume: 97
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2006.06149.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monotherapy versus combined androgen blo

Monotherapy versus combined androgen blockade in patients with advanced prostate cancer

✍ Abelardo Errejon; E. David Crawford 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB

Despite a number of large randomized clinical trials, there still is uncertainty regarding the value of maximal androgen blockade in the treatment of patients with advanced prostate carcinoma. In the referenced article, the authors provide a very comprehensive review of the literature concerning one

The patient's choice of androgen-depriva

The patient's choice of androgen-deprivation therapy in locally advanced prostate cancer: bicalutamide, a gonadotrophin-releasing hormone analogue or orchidectomy

✍ Claes R. Nyman; Jesper T. Andersen; Per Lodding; Thorsten Sandin; Eberhard Varen 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Adrenal androgen levels as predictors of

Adrenal androgen levels as predictors of outcome in castration-resistant prostate cancer patients treated with combined androgen blockade using flutamide as a second-line anti-androgen

✍ Kazutaka Narimoto; Atsushi Mizokami; Kouji Izumi; Shinya Mihara; Kiyoshi Sawada; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

Time to prostate-specific antigen nadir

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy

✍ Toni K. Choueiri; Wanling Xie; Anthony V. D'Amico; Robert W. Ross; Jim C. Hu; Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 2 views

Evaluation of quality of life in patient

Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study

✍ Yoichi Arai; Hideyuki Akaza; Takashi Deguchi; Masato Fujisawa; Mikio Hayashi; Yo 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 258 KB